Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Technology
CFOs Vow to Boost Tech Influence in 2023
Greater vigilance in overseeing technology strategy shapes up as a key priority for the coming year.
By
David McCann
| February 6, 2023
Read More
Resources
CFO Live
2022 Survey
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
2022 Survey
Sign Up
Sponsored by
biopharma
Turnarounds
GE Stock Surges on News of Biopharma Sale
The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.
By
Matthew Heller
| February 25, 2019
Read More
Strategy
LabCorp Buys U.K. Biopharma Services Firm
The $1.2 billion acquisition of Chiltern continues a wave of consolidation in the contract research organization industry.
By
Matthew Heller
| July 31, 2017
Read More
Strategy
Thermo Fisher Moves Into Drug Manufacturing
The $5.2 billion acquisition of Patheon positions Thermo Fisher to grab a slice of the fast-growing contract drug production business.
By
Matthew Heller
| May 15, 2017
Read More
Risk & Compliance
Puma Biotech Exec Accused of Insider Trading
Robert Gadimian allegedly made $1.1 million by trading on nonpublic information he learned about Puma's breast cancer drug trials.
By
Matthew Heller
| September 30, 2016
Read More
Technology
Thermo Fisher Makes Electron Microscopy Move
The lab equipment firm's $4.2 billion purchase of FEI gives it access to technology used by biopharma companies to develop drugs.
By
Matthew Heller
| May 30, 2016
Read More